Coronavirus Disease Resource List
Resources regarding the Coronavirus Disease (COVID-19)
Below is a list of resource links and recommendations regarding the Coronavirus Disease (COVID-19).
Recommendations for Cancer Patients:
From the President of the National Breast Cancer Coalition, Fran Visco:
Please note that these recommendations are from the American Society of Breast Surgeons, Commission on Cancer, NAPBC, and NCCN. Joint recommendations.
This is a link to the American Society of Breast Surgeons’ draft recommendations for breast cancer during the pandemic. The document is under review and they hope to publish the full version this week.
In order to minimize community spread of the COVID-19 virus, we recommend that patients not go to the doctor for:
1. Routine surveillance visits
2. High-risk visits/Breast cancer Prevention Program
3. Return after concordant benign core biopsies or excisional biopsies.
4. 3-month routine visits after definitive surgery for DCIS or Cancer
Routine annual mammography may always be delayed for 2-3 months without risk. Until after this acute period has passed.
We do not anticipate disruptions for patients with breast cancer.
Semi-elective surgery for DCIS or atypia should probably be delayed, so as not to utilize hospital capacity that may be needed for patients with virus related problems and to reduce exposure.
We do not expect delays in beginning chemotherapy or radiation therapy for cancer.
At the Helen F Graham Cancer Center, we are taking extreme measures to reduce the risk of exposure of patients to individuals who may be infected with COVID-19.
Diana Dickson-Witmer, MD, FACS
Medical Director, Christiana Care Breast Center and Breast Program
Helen F Graham Cancer Center and Research Institute
The situation is evolving day by day, and sometimes hour by hour. At this time, I can offer the following insight to you:
-Anyone on active or recent chemotherapy is considered immuno-compromised, and thus at higher risk for serious infection from COVID-19.
-Those on anti-hormonal therapy alone (Tamoxifen, Femara, Arimidex, etc.), are generally NOT considered immuno-compromised.
-Options for modification/delay/interruption of active treatment should be considered on an individual basis, taking into account goals of care, indication for treatment, and tolerance to treatment, and I encourage all to discuss with their medical team.
-Some patients may be able to switch from IV to oral therapies, which would decrease the frequency of clinic visits.
-Prophylactic growth factors may be of value, to decrease the risk of potential COVID-19 complications.
-Patients should be informed regarding symptoms of COVID-19, and trained in proper handwashing, hygiene, and minimizing exposure to sick contacts and large crowds
-Please refer to the CDC website for further guidance and information.
Rishi Sawhney, MD
Oncology Medical Director, Bayhealth Cancer Institute
Resources Regarding Cancer Patients
Local Cancer and Hospital Facility Updates In Alphabetical Order:
Resources for General Information and State Updates:
Delaware Health and Social Services (DHSS) State Guidelines and Precautions
• DPH has opened a COVID-19 hotline for residents at 1-866-408-1899
• Visit de.gov/coronavirus for more information.
View the list of essential and non-essential businesses as of 3/23/20 here.
FOOD, SHELTER, SUPPLIES
If you or someone you know has an immediate need such as food, shelter, or supplies - please contact the United Way of Delaware at their 211 emergency line.
Dial 2-1-1 or…
Text your Zip Code to 898-211. We can help.